Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Fred Dejonckheere
Economic Evaluation of Tocilizumab Monotherapy Compared to Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Economic Evaluation of Tocilizumab Monotherapy vs Adalimumab Monotherapy in Patients With Rheumatoid Arthritis in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms47 - Cost-Effectiveness of Tofacitinib Compared With Adalimumab in the Treatment of Moderate to Severe Rheumatoid Arthritis in Iran
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Impact of Tocilizumab Monotherapy on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis From Two Randomised Controlled Trials
RMD Open
Rheumatology
Allergy
Immunology
Long-Term Follow-Up of Adalimumab Monotherapy for Rheumatoid Arthritis in Japanese Patients: A Report of Six Cases
Rheumatology International
Rheumatology
Allergy
Immunology
PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Adalimumab in the Treatment of Early Rheumatoid Arthritis
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Treatment Persistence With Combination Versus Monotherapy in Commercially Insured Patients With Rheumatoid Arthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Receipt of Glucocorticoid Monotherapy Among Medicare Beneficiaries With Rheumatoid Arthritis
Arthritis Care and Research
Rheumatology
Efficacy of Biological Agents Administered as Monotherapy in Rheumatoid Arthritis: A Bayesian Mixed-Treatment Comparison Analysis
Therapeutics and Clinical Risk Management
